StreptokinaseMyocardial InfarctionThrombolytic TherapyAngioplasty, Balloon, CoronaryElectrocardiographyMyocardial ReperfusionFibrinolytic AgentsCoronary AngiographyTime FactorsInfarctionCreatine KinaseTreatment OutcomeTissue Plasminogen ActivatorCoronary Care UnitsProspective StudiesAnistreplaseRisk FactorsAnterior Wall Myocardial InfarctionVentricular RemodelingCerebral InfarctionShock, CardiogenicVentricular Function, LeftPlasminogenAcute DiseaseFollow-Up StudiesPrognosisHospital MortalityCoronary ThrombosisPlasminogen ActivatorsStroke VolumePredictive Value of TestsAngina PectorisMyocardiumRecurrencePlatelet Aggregation InhibitorsHeparinCoronary CirculationCoronary VesselsStentsMyocardial RevascularizationAngina, UnstableCoronary DiseaseRetrospective StudiesEchocardiographyChest PainVentricular Dysfunction, LeftStreptodornase and StreptokinaseClinical Enzyme TestsFibrinolysinAspirinBiological MarkersPercutaneous Coronary InterventionCardiac CatheterizationHirudin TherapyMyocardial IschemiaHemorrhageHospitalizationSurvival AnalysisRisk AssessmentCoronary Artery BypassRegistriesCoronary Artery DiseaseHeart Rupture, Post-InfarctionHeart FailureArrhythmias, CardiacMultivariate AnalysisTroponin TVerbal LearningIncidenceHeart VentriclesInstillation, DrugHeartProportional Hazards ModelsCohort StudiesSurvival RateFibrinolysisDrug Therapy, CombinationAdrenergic beta-AntagonistsTroponin IRandomized Controlled Trials as TopicInferior Wall Myocardial InfarctionCase-Control StudiesDouble-Blind MethodVascular PatencyEmergency Medical ServicesAge FactorsLogistic ModelsCreatine Kinase, MB FormAcute Coronary SyndromeMyocardial Reperfusion InjuryEdema, CardiacHemodynamicsAnticoagulantsOdds RatioImmunoglobulin Fab FragmentsEmpyema, PleuralCardiovascular AgentsStrokeIntra-Aortic Balloon PumpingHeart Rupture